| Viral protein interaction with cytokine and cytokine re... |
2.58 |
0.00e+0 |
84/100 (84%) |
CXCL8;CXCL1;CXCL2;...
|
| NF-kappa B signaling pathway |
2.40 |
0.00e+0 |
90/104 (86.54%) |
CXCL8;CXCL1;CXCL2;...
|
| IL-17 signaling pathway |
2.36 |
0.00e+0 |
84/94 (89.36%) |
CXCL8;LCN2;CXCL1;...
|
| Malaria |
2.23 |
0.00e+0 |
44/50 (88%) |
CXCL8;CCL2;CD81;...
|
| TNF signaling pathway |
2.13 |
0.00e+0 |
103/112 (91.96%) |
CXCL1;CXCL2;MMP9;...
|
| Amoebiasis |
2.13 |
0.00e+0 |
99/102 (97.06%) |
CXCL8;CXCL1;CXCL2;...
|
| ECM-receptor interaction |
2.08 |
0.00e+0 |
80/88 (90.91%) |
TNC;SPP1;COL6A1;...
|
| AGE-RAGE signaling pathway in diabetic complications |
2.06 |
0.00e+0 |
97/100 (97%) |
CXCL8;AGT;CCL2;...
|
| Cytokine-cytokine receptor interaction |
2.05 |
0.00e+0 |
246/295 (83.39%) |
CXCL8;CXCL1;CXCL2;...
|
| Rheumatoid arthritis |
2.04 |
0.00e+0 |
78/93 (83.87%) |
CXCL8;CXCL1;CXCL2;...
|
| Chemokine signaling pathway |
2.00 |
1.02e-3 |
163/192 (84.9%) |
CXCL8;CXCL1;CXCL2;...
|
| Complement and coagulation cascades |
1.91 |
4.66e-3 |
76/85 (89.41%) |
F13A1;CFB;C3;...
|
| Focal adhesion |
1.91 |
4.30e-3 |
180/201 (89.55%) |
PDGFRA;TNC;SPP1;...
|
| Pertussis |
1.91 |
3.99e-3 |
64/76 (84.21%) |
CXCL8;CXCL6;C3;...
|
| Mucin type O-glycan biosynthesis |
1.85 |
6.71e-3 |
20/36 (55.56%) |
GALNT11;GALNT1;B4GALT5;...
|
| Legionellosis |
1.75 |
2.38e-2 |
51/57 (89.47%) |
CXCL8;CXCL1;CXCL2;...
|
| Pathogenic Escherichia coli infection |
1.72 |
2.50e-2 |
152/197 (77.16%) |
CXCL8;ARPC1B;IL1R1;...
|
| PI3K-Akt signaling pathway |
1.70 |
3.23e-2 |
317/354 (89.55%) |
PDGFRA;TNC;SPP1;...
|
| Epithelial cell signaling in Helicobacter pylori infect... |
1.70 |
3.06e-2 |
62/70 (88.57%) |
CXCL8;CXCL1;CXCL2;...
|
| Tight junction |
1.69 |
3.13e-2 |
130/169 (76.92%) |
AMOTL2;ARPC1B;RAB13;...
|
| MicroRNAs in cancer |
1.66 |
3.62e-2 |
146/310 (47.1%) |
CYP1B1;PDGFRA;TNC;...
|
| NOD-like receptor signaling pathway |
1.65 |
3.91e-2 |
145/181 (80.11%) |
CXCL8;CXCL1;CXCL2;...
|
| Leukocyte transendothelial migration |
1.63 |
4.96e-2 |
90/114 (78.95%) |
MMP9;CLDN3;VCAM1;...
|
| Regulation of actin cytoskeleton |
1.63 |
4.94e-2 |
185/218 (84.86%) |
PDGFRA;ARPC1B;PFN2;...
|
